skip to content

FDA grants Breakthrough Device Designation for Roche's Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer's disease

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.